American Association for Cancer Research

CICR at the Annual Meeting

The annual meeting is an extraordinary venue that fosters scientific discussions and helps build bridges across various disciplines. We always encourage all annual meeting attendees to capitalize on the opportunities during the meeting to learn about the latest breakthroughs in chemistry in cancer research, and network with other scientists and clinicians interested in the field, as well as to attend sessions outside your own areas of expertise.
  
The AACR Annual Meeting 2014 was held in San Diego, Calif.; unless noted otherwise, all sessions took place in the San Diego Convention Center.

CICR will host a variety of sessions and events at the Annual Meeting:

CICR Town Meeting and Networking Reception

Monday, April 7, 2014
12:00 noon - 1:30 p.m. - Please note afternoon time.
San Diego Convention Center, Room 6D

Chairperson: Michael J. Luzzio, Ph.D., Novartis Institutes for Biomedical Research
Chairperson-Elect: Stephen A. Munk, Ph.D., Ash Stevens Inc.

The Chemistry in Cancer Research Working Group (CICR) brings together cancer-focused scientists in chemistry and chemistry-related fields to discuss the present status and future promise of chemistry in the advancement of the prevention and cure of cancer. All CICR members were encouraged to attend and all interested annual meeting registrants were also invited. This event provided an opportunity to raise questions and contribute ideas to help shape future CICR initiatives. Attendees learned about membership in CICR, met the members of the steering committee, and connected with colleagues. A networking reception followed.

Other CICR-Related Content


Award Lecture
Eighth Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research (supported by Ash Stevens Inc.)
Tuesday, April 8, 2014, 3:00 p.m. - 4:00 p.m., Ballroom 20D

Current Concepts in Diagnostics and Therapeutics

Applications of Nanotechnology for Cancer Diagnosis, Treatment, and Prevention
Sunday, April 6, 2014, 1:00 p.m. - 3:00 p.m.; Room 31A-C

Systems Pharmacology: Measuring and Harnessing Chemosensitivity on a Quantitative Omics-Driven Basis
Monday, April 7, 2014, 1:00 p.m. - 3:00 p.m.; Room 33A-C

Special Sessions

New Drugs on the Horizon 1
Sunday, April 6, 2014, 1:00 p.m. - 3:00 p.m.; Room 29

New Drugs on the Horizon 2
Sunday, April 6, 2014, 3:15 p.m. - 5:15 p.m.; Room 29

Educational Sessions

From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 1: Targeting Protein-Protein Interactions
Saturday, April 5, 2014, 8:00 a.m. - 10:00 a.m.; Room 29A-D

From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 2: Hit to Lead
Saturday, April 5, 2014, 10:15 a.m. - 12:15 p.m.; Room 29A-D

Therapeutic Nanotechnology
Saturday, April 5, 2014, 1:00 p.m. - 3:00 p.m.; Room 11

From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 3: Optimizing Drug Discovery - Insights on an Important Process
Saturday, April 5, 2014, 1:00 p.m. - 3:00 p.m.; Room 29A-D

From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 4: Oncology Clinical Development
Saturday, April 5, 2014, 3:15 p.m. - 5:15 p.m.; Room 29A-D

Career / Professional Advancement

Positions in the Biotechnology and Pharmaceutical Industry
Monday, April 7, 2014, 10:00 a.m. - 11:00 a.m.; AACRcentral

Major Symposia


New Approaches for Accessing Chemical Diversity
Sunday, April 6, 2014, 1:00 p.m. - 3:00 p.m.; Room 30A-C

Application of Nanotechnology to the Treatment of Cancer Patients
Tuesday, April 8, 2014; 10:30 a.m. - 12:30 p.m.; Room 29A-D

Targeting Non-Oncogene Addiction in Cancer
Tuesday, April 8, 2014, 1:00 p.m. - 3:00 p.m.; Room 6 CF

New Opportunities in Epigenetic Therapies
Tuesday, April 8, 2014, 1:00 p.m. - 3:00 p.m.; Ballroom 20D

Synthetic Lethality
Wednesday, April 9, 2014, 11:00 a.m. - 1:00 p.m.; Room 6B

Targeting Protein Processing in Cancer
Wednesday, April 9, 2014, 11:00 a.m. - 1:00 p.m., Room 30A-C

Chemical Genetics and Biology
Wednesday, April 9, 2014, 11:00 a.m. - 1:00 p.m., Room 6CF

Minisymposia

Understanding Mechanisms of Resistance to Targeted Agents in Patients
Sunday, April 6, 2014, 3:15 p.m. - 5:15 p.m.; Room 6B

Novel Small Molecule Inhibitors and Targets
Sunday, April 6, 2014, 3:15 p.m. - 5:15 p.m.; Room 6A

New Targets and New Combinations to Overcome Resistance
Monday, April 7, 2014, 3:00 p.m. - 5:00 p.m.; Room 6A

Novel Therapeutic Strategies
Monday, April 7, 2014, 3:00 p.m. - 5:00 p.m.; Room 25

Small Molecule Design and Optimization
Tuesday, April 8, 2014, 3:00 p.m. - 5:00 p.m.; Room 28A-C

Mechanisms of Cellular Response to Anticancer Drugs in Solid and Hematologic Malignancies
Tuesday, April 8, 2014, 3:00 p.m. - 5:00 p.m.; Room 30A-C

Novel Biologics as Targeted Cancer Therapy
Tuesday, April 8, 2014, 3:00 p.m. - 5:00 p.m.; Room 5

Meet-the-Expert

ALK Fusions and Other Essential Growth Drivers for Therapeutic Targets
Monday, April 7, 2014, 7:00 a.m. - 8:00 a.m., Room 31A-C

Cancer Pharmacogenomics: Strategies and Challenges
Tuesday, April 8, 2014, 7:00 a.m. - 8:00 a.m., Ballroom 20D

Translating Ideas into Cancer Therapeutics
Wednesday, April 9, 2014, 7:00 a.m. - 8:00 a.m., Room 31A-C

Plenary

Novel Therapeutic Combinations in Cancer: Principles and Practice
Tuesday, April 8, 2014, 8:15 a.m. - 10:15 a.m., Hall F-G

Poster Sessions

Drug Resistance 1: Hormonal Agents and Novel Mechanisms
Sunday, April 6, 2014, 1:00 p.m. - 5:00 p.m.; Hall A-E, Poster Section 29

Kinase Inhibitors 1
Sunday, April 6, 2014, 1:00 p.m. - 5:00 p.m.; Hall A-E, Poster Section 31

Multiple Drug Resistance / Antimetabolites
Sunday, April 6, 2014, 1:00 p.m. - 5:00 p.m.; Hall A-E, Poster Section 32

Experimental Gene Transfer, Vector Systems, and Antisense
Sunday, April 6, 2014, 1:00 p.m. - 5:00 p.m.; Hall A-E, Poster Section 30

Novel Cytotoxic Strategies
Sunday, April 6, 2014, 1:00 p.m. - 5:00 p.m.; Hall A-E, Poster Section 34

Novel Combinations / Retrospective Analyses
Sunday, April 6, 2014, 1:00 p.m. - 5:00 p.m.; Hall A-E, Poster Section 33

Small Molecule Design, Identification, and Optimization 1
Monday, April 7, 2014, 8:00 a.m. - 12:00 noon; Hall A-E, Poster Section 27

Proteomics and Signaling Networks
Monday, April 7, 2014, 8:00 a.m. - 12:00 noon; Hall A-E, Poster Section 26

Combination Therapy to Overcome Resistance
Monday, April 7, 2014, 8:00 a.m. - 12:00 noon; Hall A-E, Poster Section 29

New Targets and Agents 1
Monday, April 7, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 32

Resistance to Inhibitors of ErbB Proteins
Monday, April 7, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 34

Kinase Inhibitors 2
Monday, April 7, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 31

Drug Resistance 2: Proteosome Inhibitors, mTOR inhibitors, and Other Targeted Agents
Monday, April 7, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 30

Novel Targets 1
Monday, April 7, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 33

Small Molecule Design, Identification, and Optimization 2
Monday, April 7, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 26

Proteomics and Biomarker Discovery
Monday, April 7, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 25

New Targets and Agents 2
Monday, April 7, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 32

New Antibodies and Antibody Drug Conjugates
Monday, April 7, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 31

Targeting Signaling Pathways
Monday, April 7, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 35

Targeting DNA Damage, Cell Division, and Apoptosis
Monday, April 7, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 34

Novel Targets 2
Monday, April 7, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 33

Biologic Therapy 1
Monday, April 7, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 29

Biologic Therapy 2
Monday, April 7, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 30

Natural Products
Tuesday, April 8, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 10

Structural and Biophysical Approaches to Understanding Complex Biological Pathways
Tuesday, April 8, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 11

Drug Resistance 3: BRAF, MEK, ALK, and MET Inhibitors
Tuesday, April 8, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 31

Resistance to Platins, Alkylating Agents, and Temozolamide
Tuesday, April 8, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 33

Cellular and Molecular Pharmacology
Tuesday, April 8, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 30

Transcription Factors and Nuclear Targets
Tuesday, April 8, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 35

Biologic Therapy 3
Tuesday, April 8, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 29

Drug Delivery
Tuesday, April 8, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 26

Novel Drug Discovery and Delivery Systems
Tuesday, April 8, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 33

Enhanced Drug Delivery through Nanotechnology and Conjugation Strategies
Tuesday, April 8, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 27

Cell Cycle Mechanisms of Anticancer Drug Action
Tuesday, April 8, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 31

Novel Therapeutic Targets
Tuesday, April 8, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 34

Pharmacokinetics and Pharmacodynamics
Tuesday, April 8, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 35

Cell Cycle and PI3K/AKT Inhibitors
Tuesday, April 8, 2014, 1:00 p.m. - 5:00 p.m., Hall A-E, Poster Section 30

Chemical Technologies
Wednesday, April 9, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 27

Targeted Therapies and Nanoparticle Strategies for Selective Drug Delivery
Wednesday, April 9, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 28

Cellular Responses to Anticancer Drugs 1
Wednesday, April 9, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 31

Cellular Responses to Anticancer Drugs 2
Wednesday, April 9, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 32

Cellular Responses to Anticancer Drugs 3
Wednesday, April 9, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 33

Pharmacogenetics and Pharmacogenomics
Wednesday, April 9, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 35

Biologic Therapy 4
Wednesday, April 9, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 30

Epigenetic Targets
Wednesday, April 9, 2014, 8:00 a.m. - 12:00 noon, Hall A-E, Poster Section 34